Nedim Tokgozoglu
Overview
Explore the profile of Nedim Tokgozoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yalcin I, Taskin S, Takmaz O, Demirkiran F, Gungor M, Tokgozoglu N, et al.
Int J Gynecol Cancer
. 2025 Jan;
35(1):100041.
PMID: 39878290
Objective: This research was undertaken to identify risk factors for the involvement of sentinel lymph nodes (SLNs) in cases of endometrial cancer. Methods: From February 2016 to April 2021, the...
2.
Cucinella G, Schivardi G, Zhou X, AlHilli M, Wallace S, Wohlmuth C, et al.
Int J Gynecol Cancer
. 2023 Dec;
34(2):179-187.
PMID: 38088182
Objective: The prognostic significance of isolated tumor cells (≤0.2 mm) in sentinel lymph nodes (SLNs) of endometrial cancer patients is still unclear. Our aim was to assess the prognostic value...
3.
Kilic F, Ersak B, Cakir C, Yuksel D, Kilic C, Korkmaz V, et al.
J Obstet Gynaecol Res
. 2023 Oct;
50(1):86-94.
PMID: 37854000
Aim: To evaluate whether the recurrence rates, recurrence patterns, and survival outcomes differed according to the primary site of the tumor in patients with high-grade serous ovarian carcinoma (HGSOC) and...
4.
Unsal M, Kilic C, Cakir C, Kilic F, Ersak B, Karakas S, et al.
J Obstet Gynaecol
. 2022 Dec;
43(1):2151355.
PMID: 36503383
The aim of this study was to evaluate the prognostic factors for and determine the effect of neoadjuvant chemotherapy (NACT) on oncologic outcome in stage IVB pure serous endometrial carcinoma...
5.
Ersak B, Akar S, Demirayak G, Tokalioglu A, Aytekin O, Cakir C, et al.
J Obstet Gynaecol
. 2022 Aug;
42(7):3277-3284.
PMID: 36000815
In this retrospective study, patients with epithelial gynaecologic cancer with pulmonary recurrence (PR) were evaluated from five national gynaecologic oncology clinics. Patients with a diagnosis of primary endometrial, ovarian/fallopian tube/peritoneal,...
6.
Turan H, Vitale S, Kahramanoglu I, Della Corte L, Giampaolino P, Azemi A, et al.
Arch Gynecol Obstet
. 2022 Apr;
306(6):2105-2114.
PMID: 35461390
Purpose: This study aimed to evaluate trefoil factor 3 (TFF3), secreted frizzled-related protein 4 (sFRP4), reactive oxygen species modulator 1 (Romo1) and nuclear factor kappa B (NF-κB) as diagnostic and...
7.
Vural Topuz O, Aksu A, Erinc S, Tokgozoglu N, Oner Tamam M
Mol Imaging Radionucl Ther
. 2022 Feb;
31(1):16-22.
PMID: 35114747
Objectives: Endometrial cancer (EC) is the most common gynecological malignancy. The fluorine-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) is used for initial staging, evaluating treatment response, and detecting recurrence. This...
8.
Altin D, Taskin S, Ortac F, Tokgozoglu N, Vatansever D, Guler A, et al.
Gynecol Oncol
. 2022 Jan;
164(3):492-497.
PMID: 35033380
Introduction: This study aimed to evaluate the diagnostic accuracy of the sentinel lymph node (SLN) mapping algorithm in high-risk endometrial cancer patients. Methods: Two hundred forty-four patients with non-endometrioid histology,...
9.
Sahin O, Tokgozoglu N, Tasci T
Turk J Obstet Gynecol
. 2021 Sep;
18(3):264-266.
PMID: 34581175
Presented herein is the only case in literature with the synchronous development of endometrioid-type endometrium cancer and endometrioid carcinoma originating from the endometriosis foci in a scar tissue. A 44-year-old...
10.
Ghoniem K, Larish A, Dinoi G, Zhou X, AlHilli M, Wallace S, et al.
Gynecol Oncol
. 2021 Jul;
162(3):590-598.
PMID: 34274133
Objective: To assess oncologic outcomes in endometrial cancer patients with low-volume metastasis (LVM) in the sentinel lymph nodes (SLNs). Methods: Patients with endometrial cancer and SLN-LVM (≤2 mm) from December...